Compugen Ltd. (CGEN) vs Greenwich LifeSciences, Inc. (GLSI)
A side-by-side comparison of Compugen Ltd. and Greenwich LifeSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEN
Compugen Ltd.
$2.31HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GLSI
Greenwich LifeSciences, Inc.
$16.91HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CGEN vs GLSI
growth of $100 · dividends reinvested · last 6yCGEN -85.1% (-27.2%/yr)GLSI +238.2% (+22.5%/yr)GLSI compounded faster over this window
Log scale — wide-divergence pair
CGEN GLSI
CGEN vs GLSI: by the numbers
- •GLSI is the larger company ($248M vs $218M market cap).
- •CGEN is profitable (47.55% net margin) while GLSI runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CGEN | GLSI |
|---|---|---|
| P/E ratio | 6.15 | N/A |
| P/S ratio | 2.95 | N/A |
| P/B ratio | 2.46 | 79.63 |
Profitability
| Metric | CGEN | GLSI |
|---|---|---|
| Gross margin | 86.89% | 0.00% |
| Operating margin | 40.94% | 0.00% |
| Net margin | 47.55% | 0.00% |
| ROE | 39.66% | -695.56% |
| ROIC | 26.14% | -701.55% |
Growth (annualized)
| Metric | CGEN | GLSI |
|---|---|---|
| Revenue CAGR (5Y) | 105.91% | N/A |
| Total return CAGR (5Y) | -18.39% | -14.84% |
Frequently asked
- Is CGEN or GLSI more profitable?
- CGEN runs the higher net margin — CGEN at 47.55% versus GLSI at 0.00%.
- How have CGEN and GLSI total returns compared?
- Over the past 5 years, CGEN delivered -18.39% and GLSI delivered -14.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Compugen P/E ratioCompugen ROEGreenwich LifeSciences ROECompugen operating marginGreenwich LifeSciences operating marginCompugen revenue growthGreenwich LifeSciences revenue growthCompugen free cash flowGreenwich LifeSciences free cash flow
Compugen & Greenwich LifeSciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.